References | Method | n | Situation A | Situation B | p value* | Situation C | p value# |
---|---|---|---|---|---|---|---|
Persichini et al. [27] | Â | 16 | NE 0.30 | NE 0.19 | Â | Â | Â |
 |  |  | Range 0.10–1.40 | Range 0.08–1.15 |  |  |  |
 | Pmcf hold (in mmHg) |  | 33 (12) | 26 (10) | 0.003 |  |  |
Maas et al. [25] | Â | 16 | Baseline 1 | NE increase of 0.04 (0.02) | Â | Baseline 2 | Â |
 |  |  | NE 0.04 (0.03) |  |  | NE 0.04 (0.03) |  |
 | Pmcf hold (in mmHg) |  | 21.4 (6.1) | 27.6 (7.4) | < 0.001 | 22.0 (5.3) |  |
de Wit et al. [24] | Â | 17 | Propofol low | Propofol medium | Â | Propofol high | Â |
 |  |  | Cb 3.0 (0.90) μg/mL | Cb 4.5 (1.0) μg/mL |  | Cb 6.5 (1.2) μg/mL |  |
 | Pmcf hold (in mmHg) |  | 27.9 (5.4) | 24.6 (4.9) | 0.01 | 21.4 (4.2) | < 0.001 |
Helmerhorst et al. [26] |  | 22 | FiO2 21–30% | FiO2 90% |  |  |  |
 | Pmcf hold (in mmHg) |  | 20.8 (3.5) | 23.1 (4.0) | < 0.001 |  |  |